{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-067209","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.188308+00:00","generated_at":"2026-05-31T10:32:57.907372+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Denali Capital extends business combination deadline to Sep 11 via $180K Scilex note","bullets":["Deposited $15,036.74 into trust to extend deadline to Sep 11, 2024 from Aug 11.","Issued up to $180,000 convertible note to Scilex (SCLX); initial draw $15,036.74.","Note bears no interest, repayable upon business combination or liquidation; convertible at $10/share.","Remaining $164,963.26 available for future monthly extensions as needed.","If no business combination, note repaid only from non-trust funds or forfeited."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-067209","json":"https://secwatch.observer/filing/0001213900-24-067209.json","markdown":"https://secwatch.observer/filing/0001213900-24-067209.md","text":"https://secwatch.observer/filing/0001213900-24-067209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/0001213900-24-067209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/ea0211006-8k425_denali.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:32:57.907372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}